citybiz reported on Fesarius Therapeutics' $20 million Series A financing and the company's plans to expand commercial adoption of DermiSphere™ hDRT.
citybiz: Fesarius Therapeutics Raises $20 Million Series A to Expand Commercial Adoption of DermiSphere
